INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

An expert overview of the literature, useful as background reading.

357 studies · page 10 of 15

2013 / Narrative review / commentary

A review reports that higher vitamin D levels in utero or early life are linked to lower autism risk and reduced symptom severity.

This article discusses literature linking serum 25-hydroxyvitamin D [25(OH)D] concentrations to autism risk and severity. It notes a recent study where children with autism had lower serum 25(OH)D concentrations than control subjects (19 vs. 33 ng/ml) and highly significant inverse correlations between 25(OH)D and autism rating scales as well as antineuronal antibody levels. Proposed mechanisms include vitamin D's upregulation of DNA-repair genes, anti-inflammatory and antiautoimmune effects, increasing seizure threshold, protecting mitochondria, and upregulating glutathione.

Shows an association, not proof of cause and effect.

Cannell JJ, Grant WB Dermatoendocrinol, 2013. PMID 24494055

2012 / Commentary / narrative review

A commentary critiques the FDA's evaluation of synthetic food colors and neurobehavioral hazards from an environmental health perspective.

This commentary examines the U.S. FDA's review and decision not to take further action regarding synthetic food colors and adverse behavioral effects in children. The author argues that the FDA review confined itself too narrowly to the clinical diagnosis of hyperactivity rather than broader behavioral effects in the general population. It also argues the FDA failed to recognize vulnerable subpopulations and misinterpreted effect size as a criterion of risk, suggesting the issue warrants an environmental health research perspective.

Weiss B Environ Health Perspect, 2012. PMID 21926033

2012 / Narrative review

Brain imaging studies indicate that obesity and drug addiction share overlapping impairments in dopaminergic reward and control circuits.

This review integrates findings predominantly from positron emission tomography on the role of dopamine in obesity and drug addiction. Both conditions involve an abnormally enhanced saliency value of reward (food or drugs) mediated partly by dopamine increases in the limbic system that can overwhelm homeostatic control. Findings suggest that individuals with obesity or drug addiction display impairments in dopaminergic pathways regulating reward sensitivity, incentive motivation, conditioning, impulse control, stress reactivity, and interoceptive awareness. The authors propose an updated working model to assist in identifying therapeutic strategies for both conditions.

Volkow ND, Wang GJ, Fowler JS, et al. Curr Top Behav Neurosci, 2012. PMID 22016109

2012 / Narrative mini-review

Methylmercury exposure may be linked to epileptogenesis and altered seizure susceptibility in humans and animals.

This mini-review examines the impact of methylmercury (MeHg) exposure, particularly during development, on seizure susceptibility in humans and animals. It notes that patients or animals with acute or chronic MeHg poisoning often display seizures or heightened seizure susceptibility, suggesting a potential role for MeHg in epileptogenesis. The review also proposes that MeHg's preferential effect on the inhibitory GABAergic system, which disinhibits excitatory glutamatergic function, may serve as an underlying mechanism.

Shows an association, not proof of cause and effect.

Yuan Y Neurotoxicology, 2012. PMID 22206970

2012 / Narrative review

Spatial clustering studies show geographic disparities in ALS but have not established clear links to environmental factors such as BMAA.

This review examines literature on spatial clustering of amyotrophic lateral sclerosis (ALS) and investigates the potential role of environmental factors, including the cyanobacterial-derived neurotoxin beta-N-methylamino-L-alanine (BMAA). Although spatial analysis studies have identified geographical disparities in the distribution of ALS cases, they have not provided clear associations with environmental factors.

Shows an association, not proof of cause and effect.

Caller TA, Field NC, Chipman JW, et al. Amyotroph Lateral Scler, 2012. PMID 22214351

2012 / Narrative review

A gluten-free diet is proven therapy for celiac disease and aids wheat allergy, while its role in non-celiac gluten sensitivity remains an evolving area.

This review evaluates the therapeutic role of the gluten-free diet (GFD) across celiac disease (CD), wheat allergy, and gluten sensitivity. For patients with CD, a GFD is the only proven treatment improving symptoms and small bowel histology, while also managing risks of comorbid nutrition deficiencies, cancers, and autoimmune conditions. Patients with wheat allergy also benefit from avoiding wheat, though restriction of rye, barley, and oats is often unnecessary. Non-CD, non-wheat allergy gluten sensitivity involves conditions like dermatitis herpetiformis, irritable bowel syndrome, and neurologic diseases, but high-quality, large-scale randomized trials are still needed to prove the true benefits of a GFD.

Pietzak M JPEN J Parenter Enteral Nutr, 2012. PMID 22237879

2012 / Narrative review

A review indicates berry fruit consumption may enhance beneficial brain signaling and help prevent age-related cognitive and motor decline.

This review summarizes preclinical and clinical evidence on the neurological effects of berry fruits. Preclinical models show berry fruits mediate signaling pathways related to inflammation, cell survival, neuroplasticity, neurotransmission, and calcium buffering, attenuating behavioral deficits. Recent clinical trials extend these antioxidant, anti-inflammatory, and cognition-sparing effects to humans.

Miller MG, Shukitt-Hale B J Agric Food Chem, 2012. PMID 22264107

2012 / Narrative review of human epidemiologic studies

A review of low-level methylmercury exposure indicates potential effects on early growth and neurologic outcomes, with unclear findings for cardiovascular risk.

Researchers synthesized the published literature of original human epidemiologic research evaluating direct biomarkers of low-level methylmercury (MeHg) exposure. Evidence suggests possible effects of low-level MeHg on fetal growth in susceptible subgroups and infant growth in the first two years of life, while neurologic effects may vary by age, sex, and exposure timing. In contrast, no clear pattern was observed for cardiovascular disease risk across populations or specific endpoints, and studies of immunologic outcomes showed inconsistent results.

Shows an association, not proof of cause and effect.

Karagas MR, Choi AL, Oken E, et al. Environ Health Perspect, 2012. PMID 22275730

2012 / Narrative review

A review suggests polyphenol-rich diets may support brain plasticity, cognitive function, and mental health through multiple molecular pathways.

This review examines the molecular systems connecting polyphenols, the gut, and the brain, alongside published human and animal studies. Polyphenols affect a broad range of brain mechanisms, including cellular energy metabolism and signaling pathways involved in brain plasticity and oxidative stress. The authors conclude that consuming diets enriched with polyphenols may offer a non-invasive, natural, and inexpensive therapeutic approach to support a healthy brain.

Gomez-Pinilla F, Nguyen TT Nutr Neurosci, 2012. PMID 22334236

2012 / Narrative review

A review proposes four pillars of prevention and a healthy diet and active lifestyle to help reduce Alzheimer's disease prevalence.

This review discusses strategic approaches to reduce the prevalence of sporadic Alzheimer's disease (AD). The authors highlight four pillars of prevention focused on the early identification, detection, intervention, and follow-up of AD vascular risk factors. Alongside these pillars, a proactive lifestyle involving a healthy diet paired with physical and mental activity is emphasized. They note that biofactors such as micronutrients, trace metals, lipids, and pro-oxidants are involved in the pathobiological cascade of chronic brain hypoperfusion, and their modulation may help prevent or control incipient AD.

de la Torre JC Biofactors, 2012. PMID 22422426

2012 / Narrative review

Plant polyphenols, including grape and blueberry juices, show potential in the treatment of cognitive impairment in preliminary human trials and rodent studies.

This review discusses the potential role of plant polyphenols and fruit products in treating age-related cognitive disorders and dementia. Blueberry, strawberry, blackberry, grape, and plum juices or extracts have been tested in cognitively impaired rodents, and small human trials have examined grape and blueberry juice. Specific polyphenols like resveratrol and pterostilbene have been studied or shown to improve cognition in rodents. Future human trials need to consider poor bioavailability, optimal timing of therapy, and the appropriate form of treatment.

Cherniack EP Br J Nutr, 2012. PMID 22475317

2012 / Narrative review

Current evidence does not support a clear relationship between mild dehydration and cognitive performance due to methodological heterogeneity.

This review evaluated the relationship between hydration status and cognitive performance across different populations. Early studies using severe water loss induced by intense exercise or heat stress suggested alterations in short-term memory and visual cognitive function, though recent studies have not consistently confirmed these findings, and compensating water losses failed to prevent symptoms. Studies in children suggest drinking extra water may aid cognitive performance but rely on small sample sizes, while data in older adults (mean age around 60) do not strongly support an effect. Due to methodological heterogeneity, the relationship between mild dehydration and cognitive performance cannot be supported.

Sécher M, Ritz P J Nutr Health Aging, 2012. PMID 22499450

2012 / Review of case reports and case series

A review identified 60 cysticercosis cases in Canada, primarily presenting as neurocysticercosis with seizures and predominantly reported among immigrants.

A review of case reports and series identified 21 articles describing 60 patients with cysticercosis diagnosed in Canada, with 40 (67%) diagnosed in the past two decades. Most cases occurred in Ontario (n=43) and Quebec (n=14), and immigrants accounted for 96% of the 28 cases with citizenship data available. Neurocysticercosis was documented in 55 patients, isolated compromise of striated muscles in 5, and seizures served as the primary or sole manifestation in 72%. Two of seven tested patients had Taenia eggs, while household contacts were never investigated for taeniasis.

Del Brutto OH Can J Neurol Sci, 2012. PMID 22547511

2012 / Narrative review

Maternal DHA supplementation slightly enhanced gestation length and showed promising effects for reducing offspring allergic diseases.

This review examined maternal omega-3 long chain polyunsaturated fatty acid (LCPUFA) supplementation during pregnancy. Supplementation with DHA up to 1 g/d or 2.7 g n-3 LCPUFA had no harmful effects and slightly enhanced gestation length by about 2 days, which may increase birth weight by about 50 g, though no advice can be given on their general use to avoid preterm deliveries. Several studies reported neurodevelopmental improvements in offspring or positive relationships between maternal or cord serum DHA and cognitive skills. Most studies on maternal depression were judged to be of low-to-moderate quality, whereas effects on reducing allergic diseases in offspring were considered promising.

NANO counterpoint →

Larqué E, Gil-Sánchez A, Prieto-Sánchez MT, et al. Br J Nutr, 2012. PMID 22591905

2012 / Review of randomized controlled trials

Evidence from RCTs does not show a clear, consistent benefit of maternal or infant omega-3 supplementation on child growth, visual acuity, or neurodevelopment.

This review evaluated the effects of omega-3 long-chain polyunsaturated fatty acid (n-3 LCPUFA) supplementation in pregnant/lactating women and infants on child visual acuity, psychomotor development, mental performance, and growth. Across included randomized controlled trials—including 11 RCT sets during pregnancy, 2 sets during pregnancy/lactation, 3 sets during lactation, and 15 RCTs in formula-fed term infants—some reported benefits for DHA on visual acuity, long-term neurodevelopment, or growth. However, overall RCT evidence does not demonstrate a clear and consistent benefit on term infant outcomes. The authors caution that results should be interpreted carefully due to methodological limitations in the included studies.

Campoy C, Escolano-Margarit MV, Anjos T, et al. Br J Nutr, 2012. PMID 22591907

2012 / Narrative review

Brain PET imaging studies suggest reward and cognitive control regions may respond differently to food cues in obesity.

This review examines PET imaging studies on the cerebral control of obesity and food intake in humans. Evidence suggests brain regions involved in somatosensory responses to food cues may be hyperresponsive in obese individuals, executive drive areas overreact to pleasure anticipation, and cognitive/inhibitory areas may be resistant to reward perception after food exposure. The authors note that while these patterns show overlap with drug abuse, direct comparisons may be an oversimplification due to study heterogeneity and exclusion of sensitive groups.

Shows an association, not proof of cause and effect.

Iozzo P, Guiducci L, Guzzardi MA, et al. Obes Facts, 2012. PMID 22647299

2012 / Narrative review / phenomenological discussion

A review discusses the concept of food addiction within the framework of substance-related and behavioral addiction classifications.

This review analyzes the phenomenological, therapeutic, genetic, and neurobiological overlap between chemical (substance-based) and behavioral addiction in the context of food addiction. The authors note that the hormone leptin exerts a pronounced effect on the reward system, suggesting an indirect link between overeating and chemical addiction, such that leptin-deficient individuals could theoretically meet criteria for food addiction. The article evaluates the diagnostic validity of food addiction as potentially chemically and/or behaviorally based.

Albayrak O, Wölfle SM, Hebebrand J Obes Facts, 2012. PMID 22647300

2012 / Narrative review

Foods influencing tryptophan availability and serotonin/melatonin synthesis may promote sleep, based on clinical trials mostly in healthy subjects.

This narrative review examined evidence on whether ingested food and nutrients consumed before bedtime can affect sleep duration and quality, including traditional sleep-promoting items like milk and herbal products. Emerging evidence from clinical trials, largely in healthy individuals, confirms a link between diet and sleep. Foods impacting the availability of tryptophan and the synthesis of serotonin and melatonin may be the most helpful in promoting sleep. However, the authors note that the clinical relevance of these physiological effects needs to be studied further.

Peuhkuri K, Sihvola N, Korpela R Nutr Res, 2012. PMID 22652369

2012 / Narrative review

Antioxidant compounds such as N-acetyl-cysteine and curcumin show promise as potential co-adjuvants in depression treatment.

This review examines the potential role of oxidative stress processes in the pathogenesis of depression and discusses antioxidants as co-adjuvants to standard antidepressants. Major depression has been linked to decreased concentrations of endogenous antioxidants such as vitamin E, zinc, coenzyme Q10, and glutathione peroxidase, as well as impaired total antioxidant status. In human clinical evidence, N-acetyl-cysteine demonstrated significant benefit on depressive symptoms in a randomized placebo-controlled trial. Additionally, curcumin has shown antidepressant activity in various animal models of depression, partly through monoamine oxidase inhibition.

Scapagnini G, Davinelli S, Drago F, et al. CNS Drugs, 2012. PMID 22668245

2012 / Systematic review

DASH and Mediterranean dietary patterns were reported to reduce stroke risk, while a Western pattern was linked to increased risk.

A systematic review searched PubMed, Web of Science, and CINAHL Plus to evaluate the impact of food groups and dietary patterns on stroke risk. Fruits, vegetables, and soy demonstrated a protective effect, while variable findings were observed for fish, animal products, and whole grains. Adherence to DASH, Mediterranean, and prudent dietary patterns reduced stroke risk, whereas the Western pattern was associated with increased risk, and a low-fat diet showed no protective effect.

Shows an association, not proof of cause and effect.

NANO counterpoint →

Sherzai A, Heim LT, Boothby C, et al. Nutr Rev, 2012. PMID 22835136

2012 / Narrative review

Moderate reduction of salt intake is associated with reduced blood pressure and lower cardiovascular and cerebrovascular events in hypertensive individuals.

This review discusses dietary salt intake reduction in hypertensive patients. Recent meta-analyses of randomized controlled trials cited in the text indicate that moderate salt reduction is associated with reduced blood pressure and, in perspective, reduced cardiovascular and cerebrovascular events in hypertensive individuals. Patient response to salt reduction varies, primarily due to inconsistent compliance and, to a lesser extent, individual differences in blood pressure salt sensitivity.

Strazzullo P, D'Elia L, Cairella G, et al. High Blood Press Cardiovasc Prev, 2012. PMID 22867091

2012 / Narrative review

A review indicates that vascular pathology and risk factors like hypertension and diabetes may promote neurodegenerative processes in Alzheimer's disease.

This review evaluates whether vascular disease contributes to Alzheimer's disease (AD). It considers how modifiable risk factors including hypertension, atherosclerosis, diabetes, dyslipidaemia, and adiposity impact vascular structure and function. Human and animal findings indicate that vascular pathology leads to chronic cerebral hypoperfusion, which induces AD features such as selective brain atrophy, white matter changes, and amyloid beta accumulation. Evidence also suggests interventions that improve vascular function attenuate AD pathology.

Kalaria RN, Akinyemi R, Ihara M J Neurol Sci, 2012. PMID 22884479

2012 / Narrative review

Evidence suggests lutein and zeaxanthin accumulate in brain tissue and relate to cognitive function in older adults.

This review synthesizes findings linking lutein and zeaxanthin to cognitive health. In older adults, macular pigment density correlated significantly with global cognitive function, and brain zeaxanthin concentrations in deceased centenarians were significantly related to antemortem global cognition, memory retention, verbal fluency, and dementia severity. Brain lutein concentrations were significantly lower in individuals with mild cognitive impairment than in those with normal cognition. Additionally, a 4-month randomized trial in older women found that lutein (12 mg/d), alone or combined with DHA (800 mg/d), significantly improved verbal fluency scores, while memory scores and learning rate improved significantly in the combined-treatment group.

Johnson EJ Am J Clin Nutr, 2012. PMID 23053547

2012 / Narrative review

Lifelong experiences like educational and occupational attainment and leisure activities are linked to higher cognitive reserve and lower Alzheimer's risk.

This review discusses cognitive reserve as an explanation for differences in susceptibility to age-related brain changes or Alzheimer's disease pathology. Epidemiological studies suggest that lifelong experiences, including educational and occupational attainment and leisure activities in later life, can increase reserve. Specifically, the risk of developing Alzheimer's disease is reduced in individuals with higher educational or occupational attainment.

Shows an association, not proof of cause and effect.

Stern Y Lancet Neurol, 2012. PMID 23079557